(a)whether the price of insulin is controlled by the Government;
(b)if so, the details including the prices of drugs that contain insulin;
(c)whether the National Pharmaceutical Pricing Authority has submitted any
proposal for the price hike of insulin;
(d)if so, the reasons thereof and the response of the Government thereto; and
(e)the steps taken by the Government to ensure the availability of insulin at a
reasonable rate?
MINISTER OF STATE (INDEPENDENT CHARGE) OF THE MINISTRY OF
STATISTICS AND PROGRAMME IMPLEMENTATION AND MINISTER OF STATE IN
THE MINISTRY OF CHEMICALS AND FERTILIZERS (SHRI SR1KANT KUMAR JENA)
(a): Yes, Sir.
(b): The details of the prices of formulations containing Insulin during period April,
2012 to July, 2012 is enclosed as per Annexure.
(c): No, Sir.
(d): Does not arise.
(e) NPPA is also entrusted with the responsibility of monitoring the availability of drugs and to identity shortage,
if any, and to take remedial steps to make the drugs available. NPPA is carrying out this responsibility mainly through
monthly field reports from the State Drugs Controller and other available information. As and when the reports for shortage
of particular drug(s), in any part of the country are received, the concerned company is asked to rush the stock and to
make the drugs available. Generally shortage reported is brand specific. However, in most of the cases alternative brands
are available.